Mogrify Alternatives & Competitors
12 companies similar to Mogrify — Transforming the lives of patients with degenerative diseases through a novel cl...
Juvena Therapeutics
Decoding Secreted Proteins
Palo Alto, United States
Mammoth Biosciences
Improving lives by reading and writing the code of life.
Brisbane, United States
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Cambridge, United Kingdom
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Track all Mogrify competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Gandeeva Therapeutics
Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...
Canada
Verge Genomics
Better drugs, faster. For patients who can’t wait.
South San Francisco, Unit...
Cellino
Awaken your best stem cells—through machines.
Cambridge, United States
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
Afecta Pharmaceuticals
Creating Precision Medicines...More Efficiently
Irvine, United States
MOMA Therapeutics
Independently Excellent. Collectively Unstoppable.
Cambridge, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Life Biosciences
Targeting the biology of aging
Boston, United States
About Mogrify
Transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.
Development of in vivo reprogramming therapies, Direct cellular reprogramming, Cell identity platform development, Therapeutic co-development partnerships
Biopharmaceutical companies, Healthcare institutions, Regenerative medicine innovators, Research organizations focusing on degenerative diseases
Regenerative Medicine, Cell Therapy, Stem Cell Research, Drug Discovery, Gene Therapy, Transcriptomics, Bioinformatics, Machine Learning, Direct Cellular Conversion, In Vivo Reprogramming, Ophthalmology, Otology, Metabolic Diseases, Research And Development
Platform, B2B, PaaS
Licensing, Product Sales, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Mogrify and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Mogrify on 25 Mar 2025. The 12 companies listed here were last checked between 7 Jun 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.